Gen1E Lifesciences Company
GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.
Investors
Connections from
Headquarters:
Palo Alto, California, United States
Total Funding:
17025023.0
Founded Date:
2018-01-01
Employee Number:
1-10
Last Funding Type:
Venture - Series Unknown
Investor Type:
soujanya@gen1elifesci.com
Investors Number:
7.0
Last Funding Date:
2022-12-21
Technology:
['BioTech & HealthTech', 'AI Infrastructure']
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Industry:
Medical BioTech